Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Eric van Nostrand
University of California, San Diego, Department: Other Basic Sciences
Should you be removed from our database? Contact us at [email protected]. Read more below.
Eclipse BioInnovations
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Van Nostrand is a co-founder and acting chief scientific officer of Eclipse, and holds (b)(4) equity valued at (b)(4). In addition, he receives compensation at (b)(4) for providing consulting services for Eclipse. Eclipse provides eCLIP and eCLIP-seq genomics experiment as a service contractor for industry and academic customers. This project is to build upon the development of eCLIP, and develop improved methods to profile RNA binding protein targets and to integrate RNA binding protein profiling data to enable researchers to predict RNA regulators.
Robust, high-throughput identification of RNA processing regulators and regulatory networks genome-wide
PROJECT NARRATIVE Although processing of RNA has emerged as a critical regulatory step in a myriad of human diseases, our ability to understand RNA processing networks has been limited due to the lack of robust methods to identify RNA binding protein binding sites. This proposal seeks to develop improved methods to profile RNA binding protein targets in limiting or precious samples, and to develop methods to integrate RNA binding protein profiling data to enable researchers to predict RNA regulators in their system of interest.
Filed on July 20, 2018.
Tell us what you know about Eric van Nostrand's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Eric van Nostrand filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Eric van Nostrand | University of California, San Diego | Conflict of Interest | Eclipse BioInnovations | $40,000 - $59,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.